PCN64 COST-EFFECTIVENESS ANALYSIS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE (BSC) IN ADVANCED HEPATOCELLULAR CARCINOMA (AHCC)- THE PUBLIC HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72153-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)72153-7/fulltext
Section Title :
Section Order :
735
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72153-7&doi=10.1016/S1098-3015(10)72153-7